Abstract:Backgroundand objectives Rheumatoid arthritis (RA) is an autoimmune disease affecting about 1% of the population. Though of unknown aetiology, it is considered to have a strong genetic influence, resulting in the activation of different immune cells and consequent bone and cartilage destruction of the joints. The production of anticollagen type II (CII) antibodies is a common feature between RA patients and the collagen-induced arthritis (CIA) mouse model. Understanding how distinct anti-CII epitopes are genetically selected could benefit the development of new RA therapies. Here, the authors assess the genetic influence of specific anti-CII antibody production in a mouse model of RA. Material and methods In this particular study, the authors have used as genetic variance tool a heterogeneous stock (HS) mice cohort of eight inbred mouse strains. Three of the major anti-CII B cell epitopes (C1, U1 and J1) were analysed by ELISA. Sequencing of the genes coding for the M2139 monoclonal antibody (J1-specific mAb) was additionally done for all the HS strains. Results A genome wide study of antibody response during CIA development suggested that specific anti-CII antibodies are regulated by the immunoglobulin heavy chain locus (IgH). The haplotype reconstruction analysis showed a preference for the anti-J1 antibody production by certain mouse strains, in detriment of anti-C1 antibodies. The authors thus hypothesised that the selection of particular IgHv genes is responsible for this J1 versus C1 epitope selection. Preliminary sequencing data of the genes coding for the M2139 monoclonal antibody in all the HS strains, supports the initial hypothesis. The difference relies on an amino acid change from a hydrophobic tryptophan to a polar amino acid (eg, threonine) in the CDR1 region. Three-dimensional structure of M2139 Fab with triple helical J1 peptide shows that the tryptophan in the CDR1 region of the heavy chain is contacting with a hydrophobic leucine amino acid in the J1 epitope. This interaction may be essential for recognition of the J1 epitope. Replacement of Trp by Thr in this position could abrogate the binding to J1 epitope. Conclusions CIA development in HS mice allowed for a genome wide study on anti-CII specific responses. The data revealed a genetic association with the production of anti-J1 antibodies. Sequencing of the genes coding for the anti-J1 mAb reveal an amino acid substitution influencing the polarity within the CDR1 region. Cloning and expression of these mutations and consequent anti-J1 binding properties will further on confirm or reject our hypothesis.

Modification of a Fragment from Type II Collagen Affects the Dynamics of Human Class II MHC Proteins and the Subsequent T-Cell Response, Associated with Rheumatoid Arthritis

Multifunctional T Cell Reactivity to Native and Glycosylated Type-II Collagen in Rheumatoid Arthritis.

Dynamics Determine Signaling in a Multicomponent System Associated with Rheumatoid Arthritis

Definition of Mhc and T Cell Receptor Contacts in the Hla-Dr4-Restricted Immunodominant Epitope in Type Ii Collagen and Characterization of Collagen-Induced Arthritis in Hla-Dr4 and Human Cd4 Transgenic Mice

Type-II Collagen in the Pathogenesis of Rheumatoid Arthritis

Predominant Selection of T Cells Specific for the Glycosylated Collagen Type II Epitope (263-270) in Humanized Transgenic Mice and in Rheumatoid Arthritis.

The Impact of Glycosylation on Hla-Dr1-Restricted T Cell Recognition of Type Ii Collagen in A Mouse Model

Probing Molecular Interactions Within Class Ii Mhc A(Q)/Glycopeptide/T-Cell Receptor Complexes Associated With Collagen-Induced Arthritis

The Inhibitory Effect of the Altered Collagen II Peptide on T Cell Activation in Patients with Rheumatoid Arthritis

Altered Collagen II Peptides Inhibited T-cell Activation in Rheumatoid Arthritis.

T Cells Recognize A Glycopeptide Derived from Type Ii Collagen in A Model for Rheumatoid Arthritis

Hydroxyethylene isosteres introduced in type II collagen fragments substantially alter the structure and dynamics of class II MHC Aq/glycopeptide complexes

T Cell Responses to a Non-Glycosylated Epitope Predominate in Type II Collagen-Immunised HLA-DRB1*0101 Transgenic Mice

Key interactions in the trimolecular complex consisting of the rheumatoid arthritis-associated DRB1*04:01 molecule, the major glycosylated collagen II peptide and the T-cell receptor

Class Ii Major Histocompatibility Complex-Associated Response to Type Xi Collagen Regulates the Development of Chronic Arthritis in Rats

Genetic control of tolerance to type II collagen and development of arthritis in an autologous collagen-induced arthritis model.

Tissue transglutaminase enhances collagen type II-induced arthritis and modifies the immunodominant T-cell epitope CII260-270.

Role of glycopeptide-specific T cells in collagen-induced arthritis: an example how post-translational modification of proteins may be involved in autoimmune disease.

Role of EFNB1 and EFNB2 in Mouse Collagen-Induced Arthritis and Human Rheumatoid Arthritis.

Tolerance induction using lentiviral gene delivery delays onset and severity of collagen II arthritis.

Genetic Influence of Specific Anticollagen Antibody Production in A Mouse Model of Rheumatoid Arthritis